Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Conference News CRT 2024

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

L.A. McKeown

March 14, 2024

News Conference News CRT 2024

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

L.A. McKeown

March 09, 2024

News Conference News CRT 2023

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

Yael L. Maxwell

March 03, 2023

News Conference News

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

Caitlin E. Cox

March 02, 2022

News Conference News

Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients

Todd Neale

March 01, 2022

News Conference News CRT 2021

Polymer-Free Stent Noninferior to ZES at 3 Years: ReCre8

Yael L. Maxwell

March 18, 2021

News Daily News CRT 2021

COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold

Michael O'Riordan

March 17, 2021

News Conference News CRT 2021

BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients

Caitlin E. Cox

March 16, 2021

News Conference News CRT 2021

LRT Trial Data Bolster Support for TAVI in Bicuspid Valves

L.A. McKeown

March 11, 2021

News Conference News CRT 2021

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

Todd Neale

March 08, 2021

News Conference News CRT 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Michael O'Riordan

February 28, 2020

News Conference News CRT 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Michael O'Riordan

February 26, 2020

News Conference News CRT 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

L.A. McKeown

February 25, 2020

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Conference News CRT 2018

Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT

Michael O'Riordan

March 08, 2018

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

Presentation CRT 2018

Transcatheter Aortic Valve Replacement for Patients with Severe Aortic Stenosis who are at Low Risk For Mortality: Interim results from the Prospective Multicenter LRT Clinical Trial

Presenter: Ron Waksman

March 04, 2018

News Conference News CRT 2017

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Michael O'Riordan

February 21, 2017

News Conference News CRT 2016

Registry Behind TASTE Reopens Thrombus Aspiration Question With New Analysis of Stent Thrombosis

Shelley Wood

February 22, 2016

Advertisement

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients

Polymer-Free Stent Noninferior to ZES at 3 Years: ReCre8

COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold

BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients

LRT Trial Data Bolster Support for TAVI in Bicuspid Valves

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT

Ticagrelor: Better Platelet Blockade Post-TAVR?

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Transcatheter Aortic Valve Replacement for Patients with Severe Aortic Stenosis who are at Low Risk For Mortality: Interim results from the Prospective Multicenter LRT Clinical Trial

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Registry Behind TASTE Reopens Thrombus Aspiration Question With New Analysis of Stent Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content